News & Updates

Show Multimedia Only

How do parents perceive physical activity in children with cancer?

24 Jul 2025 by

The role of the family is critical to the encouragement of physical activity (PA) among childhood cancer survivors (CCS), according to a Singapore study. Apart from individuals and families, the community and society can also influence participation in PA.

How do parents perceive physical activity in children with cancer?

24 Jul 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

23 Jul 2025

New drug applications approved by US FDA as of 1-15 June 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-June-2025

23 Jul 2025

Nirsevimab efficacy against RSV-LRTI hospitalization sustained at 6 months

23 Jul 2025 by

Updated results from the phase IIIB HARMONIE trial demonstrate sustained efficacy of the long-acting monoclonal antibody nirsevimab against respiratory syncytial virus-associated lower respiratory tract infection (RSV-LRTI) hospitalization through day 181 post-dose.

Nirsevimab efficacy against RSV-LRTI hospitalization sustained at 6 months

23 Jul 2025

Early-onset neonatal sepsis ups risk of childhood epilepsy

23 Jul 2025

Infants who contract an invasive bacterial infection during the first week of life have double the risk of epilepsy in childhood, according to a register-based cohort study from Denmark.

Early-onset neonatal sepsis ups risk of childhood epilepsy

23 Jul 2025

Original New Drug Application Approvals by US FDA (16-30 June 2025)

23 Jul 2025

New drug applications approved by US FDA as of 16-30 June 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 June 2025)

23 Jul 2025

Inhaled insulin beneficial in youth with diabetes

22 Jul 2025 by

Inhaled insulin appears to be equally efficacious and safe as the injected rapid-acting insulin analogue in children and adolescents with diabetes, according to data from the INHALE-1 study.

Inhaled insulin beneficial in youth with diabetes

22 Jul 2025

Glycaemic control in early T2D improved with novel oral GLP-1 receptor agonist

21 Jul 2025 by

For adults with early type 2 diabetes (T2D) not adequately controlled by diet and exercise alone, treatment with the investigational small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron yields significant reductions in glycated haemoglobin levels, according to data from the phase III ACHIEVE-1 trial.

Glycaemic control in early T2D improved with novel oral GLP-1 receptor agonist

21 Jul 2025

Dual-Index Aspherical Lenslets deliver on myopia control in Singaporean kids

17 Jul 2025 by

Wearing spectacle lenses with Dual-Index Aspherical Lenslets (DIAL) appears to be more efficacious at slowing myopia progression in children when compared with single-vision spectacle lenses (SVLs), as shown in a study from Singapore.